Meet the surgeon: Surgical Site Complications in GO

ESGO eAcademy, Malak Moubarak, 4193921

Tumour Board Webinar: Sarcomas

ESGO eAcademy, Faculty / Presenters, 4205691

Tumour Board Webinar: Out of the box cases: Common tumours with an unusual course of disease

ESGO eAcademy, Faculty / Presenters, 4194129

ESGO Guidelines for the management of ovarian cancer - Update Part 1

ESGO eAcademy, Faculty / Presenters, 4194078

ESGO Cervical Cancer Resource - Stratified Guidelines

ESGO eAcademy, David Cibula, 4193922

Meet the Surgeon: Advanced Oncology Procedures by Robotic Approach

ESGO eAcademy, Faculty / Presenters, 4192292

Opportunistic Salpingectomy for the prevention of Ovarian Cancer: Evidence and Practice

ESGO eAcademy, Faculty / Presenters, 4194077

Surgical Mentorship Webinar: Trachelectomy

ESGO eAcademy, Faculty / Presenters, 4194128

Anal Precancerous Lesions in Women: Epidemiology, Screening and Prevention

ESGO eAcademy, Faculty / Presenters, 4205161

Invitation to ESGO 2027 in London

ESGO eAcademy, Jonathan Ledermann, 4193836

Code of Conduct

ESGO eAcademy, Jalid Sehouli, 4193835

Awards: Best Runners Award, Young Investigator Award, Quiz Award, Best Poster Award

ESGO eAcademy, Anna Fagotti, 4193834

Closing Words

ESGO eAcademy, Anna Fagotti, 4193831

Closing Words

ESGO eAcademy, Mansoor Raza Mirza, 4193833

Closing Ceremony

ESGO eAcademy, Faculty / Presenters, 4193902

Discussant

ESGO eAcademy, Pedro Ramirez, 4193830

Perioperative complications as secondary outcomes in the RACC randomized trial of robot-assisted versus open radical hysterectomy

ESGO eAcademy, Henrik Falconer, 4194638

Quality of life and lower-limb lymphoedema after sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: results from the prospective multicentre SENTIX study (CEEGOG-CX01; ENGOT-CX2; NCT02494063)

ESGO eAcademy, Roman Kocian, 4193829

Simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: an exlploratory analysis from the GCIG/CCTG CX.5/SHAPE trial

ESGO eAcademy, Se Ik Kim, 4193828

KORE-INNOVATION: main results of a prospective trial of prehabilitation and enhanced recovery after surgery in ovarian cancer patients across two ESGO centers of excellence for surgery in advanced ovarian cancer

ESGO eAcademy, Jalid Sehouli, 4193827

Best Oral Session 4: Miscellaneous

ESGO eAcademy, Faculty / Presenters, 4193901

Patient-reported outcomes from ENGOT-ov65/KEYNOTE-B96: a phase 3, randomized, double-blind study of pembrolizumab vs placebo plus paclitaxel with or without bevacizumab for platinum-resistant recurrent ovarian cancer

ESGO eAcademy, Emese Zsiros, 4193826

Discussion

ESGO eAcademy, Faculty / Presenters, 4193821

Discussion

ESGO eAcademy, Faculty / Presenters, 4193825

Discussion

ESGO eAcademy, Anna Fagotti, 4193817

Management of Adverse Events

ESGO eAcademy, Antonio Gonzalez Martin, 4193816

Are ADCs still just Chemotherapy in New Package?

ESGO eAcademy, Iain Mcneish, 4193820

Myth and Facts of Enhanced Recovery after Surgery in Gynaecologcial Oncology

ESGO eAcademy, Jalid Sehouli, 4193824

How to Manage Oligometastatic Disease

ESGO eAcademy, Anna Fagotti, 4193815

New Treatments in Endometrial Cancer

ESGO eAcademy, Domenica Lorusso, 4193814

Is the Target Important, or Are We just Shooting at Random?

ESGO eAcademy, Toon Van Gorp, 4193819

How and When to Integrate Prehabilitation into Gynaecologcial Oncology

ESGO eAcademy, Marlene Lee, 4193823

Predictive Biomarkers

ESGO eAcademy, Alexandra Leary, 4193813

The Combination Therapy in the Era of Targeted Therapy

ESGO eAcademy, Christian Marth, 4193812

Grand Rounds 6: Endometrial Cancer

ESGO eAcademy, Faculty / Presenters, 4193898

Which ADCs Are New and Promising in the Treatment of Gynaecological Cancer?

ESGO eAcademy, Angelica Rodrigues, 4193818

The Era of ADCs in Gynaecological Malignancies

ESGO eAcademy, Faculty / Presenters, 4193899

Expanding the Management in Gynaecological Cancer Surgery. The Role of Critical Care - Beyond Traditional Perioperative Care

ESGO eAcademy, Nikolaos Thomakos, 4193822

Treatment Planning and Perioperative Care: Myths, Facts and Practical Applications

ESGO eAcademy, Faculty / Presenters, 4193900

Introduction

ESGO eAcademy, Anna Fagotti, 4193811

Session 9: Advocacy Best Practice Sharing

ESGO eAcademy, Faculty / Presenters, 4193896

Stereotactic radiotherapy versus secondary cytoreduction in the management of first recurrence during and after PARP inhibitor maintenance in ovarian cancer: A propensity matched analysis

ESGO eAcademy, Matteo Loverro, 4193796

Discussion

ESGO eAcademy, Faculty / Presenters, 4193808

Discussion

ESGO eAcademy, Faculty / Presenters, 4193804

The surgery in recurrent ovarian cancer research consortium (suROC-CON): value of secondary cytoreduction for recurrent epithelial ovarian cancer in a multicenter, high surgical quality setting

ESGO eAcademy, Irina Tsibulak, 4193795

Ovarian cancer incidence according to subtype of endometriosis: a population based study

ESGO eAcademy, Marlot Uffing, 4193794

Novel Treatment Approaches in Early Stage Disease

ESGO eAcademy, Toon Van Gorp, 4193803

Efficacy and safety of immune checkpoint inhibitor rechallenge in cervical and endometrial cancer: A multi-center retrospective study - RICE study

ESGO eAcademy, Rayan Kabirian, 4193793

Laterally Extended Pelvic Resections: Muscular, Osseal and Vascular Involvement

ESGO eAcademy, Zoltan Novak, 4193807

Risk Stratified Radiation Therapy

ESGO eAcademy, Remi Nout, 4193802

Beyond recurrence site: molecular profile determines prognosis after relapse in endometrial cancer

ESGO eAcademy, Ana Luzarraga, 4193792

State of the Art in Surgical Treatment

ESGO eAcademy, Nadeem R. Abu-Rustum, 4193801

Tumour immune microenvironment signatures by RNA profiling predict prognosis in dMMR endometrial cancer

ESGO eAcademy, Carlos Casas Arozamena, 4193791

Upper Abdominal Resections: Coeliac Nodes, Porta Hepatis, and Hepatic Pedicle

ESGO eAcademy, Mario Leitao Jr., 4193806

Multiple Classifiers

ESGO eAcademy, Xavier Matias-Guiu, 4193800

Integration of inflammatory markers and ultrasound features to improve preoperative diagnosis in high-risk patients with uterine mesenchymal tumors: the IMPRINT study

ESGO eAcademy, Matteo Bruno, 4193790

Molecular Classification and Risk Stratification

ESGO eAcademy, Nicole Concin, 4193799

Ultrasound features of malignant transformation of deep endometriosis: preliminary results from a multicentre descriptive study.

ESGO eAcademy, Eleonora Panizzolo, 4193789

Patient Story

ESGO eAcademy, Sidsel Eriksen, 4193798

Introduction

ESGO eAcademy, Nicole Concin, 4193797

Grand Rounds 5: Endometrial Cancer

ESGO eAcademy, Faculty / Presenters, 4193894

Thoracic: Managing the Cardiophrenic Region

ESGO eAcademy, Alejandra Martinez, 4193805

Out of the Box Procedures: The Challenge of Extended Resections at the Thorax, Abdominal and Pelvic Levels

ESGO eAcademy, Faculty / Presenters, 4193895

Young Investigator Session

ESGO eAcademy, Faculty / Presenters, 4193893

Risk of ovarian cancer in women with a pathogenic or likely pathogenic variant in NBN in 38,337 women: a systematic review and meta-analysis

ESGO eAcademy, Subhasheenee Ganesan, 4193788

Discussion

ESGO eAcademy, Faculty / Presenters, 4193782

Discussion

ESGO eAcademy, Faculty / Presenters, 4193786

Discussant

ESGO eAcademy, Anniina Färkkilä, 4193778

Surgery in Transition: How AI and Less Radical Approaches Are Shaping Gynaecologic Oncology

ESGO eAcademy, Andrej Cokan, 4193785

MINERVA study - update of the anatomosurgical classification of retrograde hysterectomy and rectal resection in ovarian cancer: impact on survival outcomes

ESGO eAcademy, Andrea Rosati, 4193777

Neoadjuvant Approach

ESGO eAcademy, Alejandra Martinez, 4193781

Genomic instability in advanced ovarian carcinoma: analysis of a french cohort of 1,324 patients.

ESGO eAcademy, Witold Gertych, 4193776

Precision Surgery and Personalized Surgery

ESGO eAcademy, Ane Gerda Z Eriksson, 4193784

Radiotherapy

ESGO eAcademy, Remi Nout, 4193780

The European Society of Gynaecological Oncology (ESGO) consensus statements on opportunistic salpingectomy for the prevention of epithelial ovarian cancer

ESGO eAcademy, Jurgen Piek, 4193775

Session 8: Clinical trials WORKSHOP

ESGO eAcademy, Faculty / Presenters, 4193892

Facing the Operating Room: 3D Reconstruction Images as Support in Gynaecologic Oncology

ESGO eAcademy, Alvaro Tejerizo, 4193783

Risk of ovarian cancer among women with a pathogenic variant in BRCA1 according to mutation type and location

ESGO eAcademy, ADRIANA IONELIA APOSTOL, 4193774

Best Oral Session 3: Ovarian Cancer

ESGO eAcademy, Faculty / Presenters, 4193889

Surgical Trends of the Future

ESGO eAcademy, Faculty / Presenters, 4193891

Intermediate-Risk Cervical Cancer - The Best Strategy?

ESGO eAcademy, Faculty / Presenters, 4193890

Surgery

ESGO eAcademy, David Cibula, 4193779

Double-barreled wet colostomy in ten steps

ESGO eAcademy, Maria Selloua, 4193769

What burdens patients with endometrial cancer most: results of the international EXPRESSION XI/IMPROVE survey with 2.761 patients

ESGO eAcademy, Sara Nasser, 4193763

Post-hoc survival outcomes based on initial and subsequent treatment in patients with mmrp/MSS primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial

ESGO eAcademy, Dominik Denschlag, 4193762

Discussion

ESGO eAcademy, Faculty / Presenters, 4193772

Laparoscopic vesicovaginal fistula repair in a patient with a history of radiotherapy for cervical cancer

ESGO eAcademy, Selçuk Erk?l?nç, 4193768

Indirect treatment comparison of durvalumab plus carboplatin/paclitaxel followed by durvalumab plus olaparib versus dostarlimab plus carboplatin/paclitaxel followed by dostarlimab as first-line treatment for mismatch repair proficient endometrial cancer

ESGO eAcademy, Jalid Sehouli, 4193761

Pelvic sentinel lymph node dissection using vNOTES assisted by single-port robotic system: video demonstration of a novel minimally invasive technique

ESGO eAcademy, Louise Moniod, 4193767

Morbidity reduction using sentinel lymph node biopsy in intermediate and high-risk early-stage endometrial cancer: a prospective multicenter trial (sentirad)

ESGO eAcademy, Lucie BRESSON, 4193760

A multicenter retrospective study comparing one step nucleid amplification (OSNA) and conventional ultrastaging for sentinel lymph node assessment in early-stage endometrial cancer

ESGO eAcademy, Elvira Valles Nunez, 4193759

Is TRUST Actually TRUSTworthy?

ESGO eAcademy, Suk-Joon Chang, 4193771

Keeping it MIS: suprapubic uterine manipulation technique

ESGO eAcademy, Maureen Byrne, 4193766

Prognostic role of LVSI quantification assessed prospectively; results from the PORTEC-4a trial

ESGO eAcademy, Anne Sophie Van Den Heerik, 4193758

Laparoscopic sentinel lymph node biopsy and pelvic lymphadenectomy for early- stage cervical adenocarcinoma during pregnancy

ESGO eAcademy, Piercarlo Zorzato, 4193765

POLARIX: POLE-mutation analysis by rapid image-based screening in endometrial cancer

ESGO eAcademy, Cornelis D de Kroon, 4193757

Sentine node positive POLE-mutated endometrial cancer

ESGO eAcademy, Giorgio Bogani, 4193756

Mini Oral Session 4: Endometrial Cancer

ESGO eAcademy, Faculty / Presenters, 4193885

Video Session 4: Endometrial and Cervical Cancer

ESGO eAcademy, Faculty / Presenters, 4193886

Ovarian Cancer Surgery in the Best Interest of the Patient (PRO)

ESGO eAcademy, Sven Mahner, 4193770